Publication Name	World Journal of Diabetes
Manuscript ID	68536
Country	United Arab Emirates

Category	Medicine, Research & Experimental
Manuscript Type	Retrospective Cohort Study
Article Title	Utility of oral glucose tolerance test in predicting type 2 diabetes following gestational diabetes: Towards personalized care
Manuscript Source	Unsolicited Manuscript
All Author List	Riad Abdel Latif Bayoumi, Amar Hassan Khamis, Muna A Tahlak, Taghrid F Elgergawi, Deemah K Harb, Komal S Hazari, Widad A Abdelkareem, Aya O Issa, Rakeeb Choudhury, Mohamed Hassanein, Jeyaseelan Lakshmanan and Fatheya Alawadi
Funding Agency and Grant Number	Funding Agency Grant Number Al Jalila Foundation AJF2015
Corresponding Author	Riad Abdel Latif Bayoumi, MBBS, PhD, Professor, Department of Basic Medical Sciences, College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Building 14, Dubai Healthcare City, Dubai 123, United Arab Emirates. riad.bayoumi@mbru.ac.ae
Key Words	Type 2 diabetes; Type 2 diabetes subtypes; Oral glucose tolerance test; Diabetes; Gestational diabetes mellitus subtypes
Core Tip	The oral glucose tolerance test (OGTT) remains the gold standard for assessing the risk of postnatal diabetes in women with gestational diabetes mellitus (GDM). Both the fasting blood glucose and 2-h blood glucose tests could predict postpartum abnormal glycemic status following antenatal GDM. However, each test reflects a different pathophysiology and possible subtype of type 2 diabetes (T2D). If fasting serum insulin measurements are added to an OGTT, additional data generated could distinguish T2D pathophysiology and possible subtypes. Information obtained could be used to match the T2D subtype with relevant prevention programs such as frequent follow-ups, lifestyle modifications, and new treatment protocols.
Citation	Bayoumi RAL, Khamis AH, Tahlak MA, Elgergawi TF, Harb DK, Hazari KS, Abdelkareem WA, Issa AO, Choudhury R, Hassanein M, Lakshmanan J, Alawadi F. Utility of oral glucose tolerance test in predicting type 2 diabetes following gestational diabetes: Towards personalized care. World J Diabetes 2021; 12(10): 1778-1788

Received	2021-05-31 08:04
Peer-Review Started	2021-05-31 08:07
To Make the First Decision
Return for Revision	2021-06-24 17:08
Revised	2021-07-05 10:08
Second Decision	2021-08-30 03:32
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2021-08-30 09:43
Articles in Press	2021-08-30 09:43
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2021-10-11 04:20

ISSN	1948-9358 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com